ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
5 hedge funds and large institutions have $42.5K invested in ENVUE MEDICAL INC NEW in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
348% more capital invested
Capital invested by funds: $9.5K → $42.5K (+$33K)
1.54% more ownership
Funds ownership: 0.15% → 1.69% (+1.5%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$77.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.54K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$113 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.64K |
FEED Hedge Fund Activity: Q4 2025 in Review
5 of the 8,280 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q4 2025, worth a combined $42.5K — up 348% from $9.5K a quarter earlier.
Fund positioning in FEED was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $77.7K. The largest seller was Morgan Stanley, exiting entirely with an estimated $5.64K sold.
- 5 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $42.5K of ENVUE MEDICAL INC NEW stock for Q4 2025, up 348% quarter-over-quarter.
- 1 fund opened new ENVUE MEDICAL INC NEW positions in Q4 2025 and 1 closed out, a net change of 0 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q4 2025 was Citadel Advisors, an estimated $77.7K added.
- The largest ENVUE MEDICAL INC NEW seller in Q4 2025 was Morgan Stanley, an estimated $5.64K sold.
Based on aggregated 13F filings for Q4 2025.